Filing Flows

Filing Flows › Axsome Therapeutics (AXSM) › Who owns the stock

Who owns Axsome Therapeutics (AXSM) stock

476 funds reported Axsome Therapeutics (AXSM) shares in their latest 13F filings, worth $9.7B in all. The largest holder is Vanguard Group ($761M). Last quarter 264 funds added to their stakes and 180 cut them.

Largest holders of AXSM (13F)Largest holders of AXSM (13F)Vanguard Group$761MBlackRock$760MVanguard Portfolio Management LLC$486MVanguard Capital Management LLC$481MInvesco$409MFMR LLC$377MGeode Capital Management, LLC$237MMorgan Stanley$197MState Street$192MDeep Track Capital, LP$171M

Largest holders (13F)

FundSharesValueChangeQuarter
Vanguard Group4,164,818$761Mdecrease2025-12-31
BlackRock3,103,708$760Mdecrease2026-06-30
Vanguard Portfolio Management LLC1,983,514$486Mdecrease2026-06-30
Vanguard Capital Management LLC1,965,086$481Mincrease2026-06-30
Invesco1,671,684$409Mincrease2026-06-30
FMR LLC1,539,163$377Mdecrease2026-06-30
Geode Capital Management, LLC967,172$237Mdecrease2026-06-30
Morgan Stanley804,082$197Mincrease2026-06-30
State Street785,661$192Mdecrease2026-06-30
Deep Track Capital, LP700,000$171Mdecrease2026-06-30
Two Sigma Investments, LP669,478$164Mincrease2026-06-30
Franklin Resources668,373$164Mincrease2026-06-30
Wellington Management Group LLP653,920$160Mdecrease2026-06-30
Alethea Capital Management, LLC648,756$159Mdecrease2026-06-30
Price T Rowe Associates642,893$157Mdecrease2026-06-30

Axsome Therapeutics' latest quarter

Axsome Therapeutics, Q3 2026: revenue $260M (+52% year over year), operating margin -4.3%, net loss $12.9M, operating cash flow −$9.5M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most AXSM stock?

By the latest 13F filings: Vanguard Group ($761M); BlackRock ($760M); Vanguard Portfolio Management LLC ($486M); Vanguard Capital Management LLC ($481M); Invesco ($409M).

What is the short interest in AXSM?

3,111,573 shares were sold short at the 2026-10-15 settlement, -5.89% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.